Reference
Han C, et al. Afatinib, an effective treatment for patient with lung squamous cell carcinoma harboring uncommon EGFR G719A and R776C co-mutations. Journal of Cancer Research and Clinical Oncology 148: 1265-1268, No. 5, May 2022. Available from: URL: http://doi.org/10.1007/s00432-021-03864-4
Rights and permissions
About this article
Cite this article
Afatinib. Reactions Weekly 1906, 25 (2022). https://doi.org/10.1007/s40278-022-14915-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-14915-8